TriSalus Life Sciences

TLSINasdaq United States Health Care Medical Specialities

Market cap

$303.563 M

$4.93 -1.00%

Close of 22 Sept 2026

Revenue

$45.2M

#2762 by revenue

Earnings

-$39.2M

Loss-making

Shares outstanding

61,574,600

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

TriSalus Life Sciences lists more than one class of stock. Company figures above cover all classes combined.

TLSIW

Medical Specialities, ranked by market cap

All 44 →

#30Lumexa ImagingLMRI$1.01B
#31Fulgent GeneticsFLGT$595.7M
#32TriSalus Life SciencesTLSI$303.6M
#33BiodesixBDSX$297.0M
#34ExagenXGN$211.7M

What if TriSalus Life Sciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$491,013.66

Per share 99,597× higher

Bitcoin $1.74T

$28,285.28

Per share 5,737× higher

Nvidia $5.52T

$89,578.61

Per share 18,170× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for TriSalus Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.